济南早泄因为什么原因(济南白色念珠菌能治好吗) (今日更新中)

What are Apple’s Black Friday 2020 plans?As we all know, Apple doesn’t have “discount” in its DNA. While Apple tempts us with its latest technology, Black Friday deals often come from retailers clearing out last-generation inventory. Apple has introduced the iPhone 12 Pro and iPhone 12 Pro Max, but any discounts you find will likely be tied to contracts with carriers.All of which means you might have to do a little more work to find Black Friday deals on Apple tech. We’ve done some of that shopping reconnaissance for you.What are Apple’s Black Friday 2020 deals?Here’s what we know so far:AT&T is offering a credit up to 0 on an eligible smartphone trade-in with an upgraded or new line and the purchase of an iPhone 12.Best Buy will be offering discounts up to 0 on select MacBook Pros and up to 0 on select iPad Pros (through Nov. 28).Walmart will have AirPods Pro for 9 ( savings) and Apple Watch Series 3 (GPS) for 9 ( savings), both online only.Amazon hasn’t leaked any significant Apple discounts yet; off here, there. The best we’ve found is a 2017 model iPad Pro for 0.84 (.16 savings).How can you save money on Apple products?Here are a couple of ways to save on Apple products. First, with an Apple Card, you can get 3% cash back when you buy directly from Apple. You’ll also have the option to pay in monthly installments with zero interest charged, with approved credit.And iPhone or iPad owners can receive up to a 0 credit toward the purchase of a new Apple product with Apple Trade In.What were Apple’s Black Friday 2019 deals?Apple products are customer magnets during the holidays. Here are some of the Black Friday specials from last year:Apple offered gift cards ranging from to 0 with the purchase of select Apple and Beats products.HomePods were discounted to 9.99 (regularly 9).Target featured a 0 gift card with the qualified activation of an iPhone 11 or iPhone XS with Verizon or AT&T.Walmart sold the Apple Watch Series 3 (GPS) 38mm for 9 (regularly 9).More From NerdWalletSmart Money Podcast: The Holiday Shopping EpisodeIPhone Black Friday 2020 Deals: Are They Worth It?Cell Phone Black Friday 2020 Deals: Are They Worth It?Hal M. Bundrick, CFP is a writer at NerdWallet. Email: hal@nerdwallet.com. Twitter: @halmbundrick. 2332

With millions of Americans getting tested for COVID-19 every single day, some are struggling with long waits for results.But now, researchers say there’s a much easier and faster way to test for the virus, and its right under your nose.“You scratch it, smell it, and then you have a choice of these different windows and you pick which one,” said Derek Toomre, Ph.D., a professor at Yale University School of Medicine.Toomre is part of U-Smell-It, a team that created a scratch-and-sniff app to help determine if someone has COVID-19 all through the sense of smell.“It's going to see how good your sense of smell is and if you do really well, you’ll pass,” Toomre said. “And if you don’t, it will say, ‘hey, you got something up.’”Despite being less accurate than a COVID-19 diagnostic test, this product is much faster and less costly. With results available in less than a minute and the cards costing 50 cents a pop, scientists say this smell app could outperform traditional tests at a fraction of the price.“We’re all familiar with the idea of testing people for fever as a way of finding people who have COVID,” said Roy Parker, Ph.D. a biochemistry professor at the University of Colorado, Boulder. “But that hasn’t worked very well.”Parker says with only about 20% of people with COVID-19 getting a fever, compared to 80% of people with COVID-19 reporting a loss a smell, a smell test is a much better indicator of COVID-19 infection than a temperature check.“It would make a big difference because you would identify people who have COVID, but they have such mild symptoms that they don’t know it and they’re out walking around potentially infecting other people and their family,” Park said.While commercially available, U-Smell-It is now looking for emergency FDA approval with the goal of getting their scratch-and-sniff cards into people’s hands and under their noses as quick as possible.“I can see people saying, ‘hey, this is not serious,’ and that’s fine, don’t take it serious,” Toomre said. “Let’s just try to do it and see if it works. And if you can’t smell that test and it’s saying, ‘hey, there’s something up’ well, you know, you should isolate and check out.” 2192

When he was diagnosed with two autoimmune diseases, Joel Hechler knew he’d be in for a battle. He didn’t realize maybe his toughest one would be with his insurance company.“I think they put the dollars ahead of a patient’s health,” Hechler said. “I don’t think they fully understand the impact the medicine will have on my long-term health and well-being."Hechler suffers from Crohn’s disease and ulcerative colitis, diseases that attack the lining of his digestive tract. Autoimmune conditions like his can’t be cured but, with the right medication, the symptoms can be controlled.  Finding the right medicine can be hard for those suffering from autoimmune diseases. Even if there are scores of drugs on the market, some patients might only respond to one. In Joel’s case, his doctor thought he’d have a better chance trying a drug called Remicade.“I received a letter from my insurance company that denied the Remicade on the basis that I have to try a different drug before I can get to Remicade," Hechler said.Hechler's insurance company, Premera Blue Cross, wouldn’t approve the drug his doctor prescribed because they wanted him to try a cheaper one first.It’s part of a program that health insurers nationwide use called step therapy, requiring that patients try less-costly drugs before “stepping up” to more expensive ones — even if doctors believes the cheaper drug won’t work.Dr. Larry Adler is president of Huron Gastro in Ypsilanti, Michigan and says he spends virtually every day battling insurance companies over step therapy drugs.“They have to fail this medicine first before they get the new drug,” Adler said. “That doesn’t make any sense.”Adler says it's common for patients to get sicker while waiting for step therapy to run its course.In Hechler's case, it took six weeks of fighting with his insurer to convince them that the cheaper drug wouldn’t be effective. As he was waiting, he was getting worse.“It got to the point where I had to be admitted to the hospital,” Hechler said. "I was very, very sick.”Step therapies are used by insurers to try to control skyrocketing prescription medicine costs, says Glen Perry, Director of Pharmacy Contracting and Sales for Blue Cross Blue Shield of Michigan.“These drugs can cost up to 0,000 per year. These are not cheap medications,” Perry said.“It seems like you’re telling patients that, in many cases, your insurer knows what’s best for you, rather than your doctor,” Jones said.“We are trying to provide the most cost effective and safe medication use,” Perry said, adding that when a doctor and insurer disagree over a drug, they can usually resolve the case within a few days without putting a patient at serious risk.“A delay of one or two days I don’t think is really going to make that much of a difference for the medical outcome of the patient," he said.But for many patients, like Phyllis Toole, the delay is longer than a few days.Phyllis suffers from rheumatoid arthritis, a condition where her body attacks her joints. When her doctor wanted to put her on Orencia, her insurance company HAP said she needed to first try a less expensive drug, Humira.But Phyllis’ doctor was worried about possible side effects and thought Humira could be risky.After battling for months, Phyllis says the whole thing made her feel more like a number than a patient. With her doctor and insurer in a standoff, she was forced to rely on samples of the drug she got from her doctor. HAP never approved her prescription.“They’re playing doctor, is what it feels like,” Toole said. “They’re saying this is what you can have for the symptoms you have. It may make you sicker, but this is what you can have.”HAP issued the following statement to Scripps station WXYZ in Detroit: 3800

WILLIAMSVILLE, NY — Rep. Chris Collins, who was charged with insider trading Wednesday, has announced in a statement that he will be suspending his campaign for re-election to Congress in New York's 27th District. Collin's Statement: 266

When Madame Tussauds Wax Museum reopens on Friday, President Donald Trump's wax figure will greet anyone who walks in, while donning a mask. 148

来源：资阳报